drugset / Trial / NCT00003824
S9809, Ciprofloxacin Compared With Cephalexin in Treating Patients With Bladder Cancer
Phase 3
Terminated
114 enrolled
SWOG Cancer Research Network
National Cancer Institute (NCI) · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. It is not yet known whether ciprofloxacin is more effective than cephalexin in preventing cancer recurrence in patients who are undergoing surgery to treat bladder cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of ciprofloxacin with that of cephalexin in preventing recurrence of cancer in patients who are undergoing surgery for bladder cancer.
Timeline
- Start
- 1999-04
- Primary completion
- 2001-07
- Completion
- 2007-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CEPHALEXIN ANHYDROUS | Small molecule | 500 mg | Oral |
| Subject | Ciprofloxacin | Small molecule | 500 mg | Oral |